期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
Mesenchymal stem cell as a novelapproach to systemic sclerosis;currentstatus and future perspectives 被引量:1
1
作者 Mina Abedi sepideh alavi-moghadam +5 位作者 Moloud Payab Parisa Goodarzi Fereshteh Mohamadi-jahani Forough Azam Sayahpour Bagher Larijani Babak Arjmand 《Cell Regeneration》 2020年第1期207-225,共19页
Systemic sclerosis is a rare chronic autoimmune disease with extensive microvascular injury, damage of endothelialcells, activation of immune responses, and progression of tissue fibrosis in the skin and various inter... Systemic sclerosis is a rare chronic autoimmune disease with extensive microvascular injury, damage of endothelialcells, activation of immune responses, and progression of tissue fibrosis in the skin and various internal organs.According to epidemiological data, women’s populations are more susceptible to systemic sclerosis than men. Untilnow, various therapeutic options are employed to manage the symptoms of the disease. Since stem cell-basedtreatments have developed as a novel approach to rescue from several autoimmune diseases, it seems that stemcells, especially mesenchymal stem cells as a powerful regenerative tool can also be advantageous for systemicsclerosis treatment via their remarkable properties including immunomodulatory and anti-fibrotic effects.Accordingly, we discuss the contemporary status and future perspectives of mesenchymal stem cell transplantationfor systemic sclerosis. 展开更多
关键词 Anti-fibrotic effect Autoimmune disease Cell therapy IMMUNOMODULATION Mesenchymal stem cells Regenerative medicine Systemic sclerosis
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部